September 19, 2016 Bio/Pharma/CRO Product Launch

GE to invest €150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT

CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork.  GE BioPark Cork, subject to contract and planning approvals,... Read more

September 8, 2016 Bio/Pharma/CRO

Collected application know-how for pharmaceutical analysis

Metrohm is pleased to present «Pharmaceutical analysis», a dedicated online resource providing an overview of the most important methods and applications for the determination of active ingredients, excipients, and impurities in pharmaceuticals. «Pharmaceutical analysis» draws on Metrohm’s comprehensive expertise in chemical analysis for the quality control of pharmaceuticals. Using the U.S. Pharmacopeia as a reference,... Read more

August 16, 2016 Bio/Pharma/CRO M&A, Partnerships

GE Healthcare and Sealed Air enter an exclusive agreement to deliver film for single-use bioprocess systems

CHALFONT ST. GILES, UK and CHARLOTTE, NC – 17 August 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries and Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, today announced the expansion of a strategic alliance designed to further... Read more

August 9, 2016 Bio/Pharma/CRO Industrial Product Launch

Applied quality control in the chemical industry – new web pages answer your questions

We are making the chemical engineer’s life a bit more comfortable: A new section on the Metrohm website takes a comprehensive look at the methods and applications used in the quality control of the industrial manufacturing of basic chemicals, solvents, colorants, and their intermediates. Whether you are looking for a specific parameter and suitable methods... Read more

July 23, 2016 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

QIAGEN Exchange Offer for Digene Corporation Expired With Significant Over 90% of Shares Tendered

VENLO, The Netherlands, July 23 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation (Nasdaq: DIGE) expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions of the exchange offer... Read more

June 21, 2016 Bio/Pharma/CRO Licensing, IP, and Legal M&A, Partnerships

Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma

Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma Kusatsu/Shiga, Japan — June 21, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Kite Pharma, Inc. (“Kite”), United States, under which Takara Bio grants Kite a commercial license to use applicable patents relating... Read more

June 13, 2016 Bio/Pharma/CRO Liq. Handling & Robotics Product Launch

GE Healthcare launches next generation Biacore(TM) molecular interaction analysis platform

CHALFONT ST. GILES, UK – 13 June 2016 – GE Healthcare’s Life Sciences business today launched the first of a next generation of BiacoreTM systems harnessing Surface Plasmon Resonance (SPR) technology. Biacore 8K marks the start of a new generation of Biacore systems maintaining the high data quality expected from Biacore at high throughput. New... Read more

May 19, 2016 Bio/Pharma/CRO Clinical Research/Diagn. PR/Corporate

Takara Bio presents HF10 Phase II clinical trial data at American Society of Clinical Oncology

2016 2016/05/19 Takara Bio presents HF10 Phase II clinical trial data at American Society of Clinical Oncology Kusatsu/Shiga, Japan — May 19, 2016 – Takara Bio Inc. announces that HF10 US Phase II clinical trial data will be presented at  the 2016 Annual Meeting of the American Society of Clinical Oncology (May29 – June 2, 2016,... Read more

May 9, 2016 Bio/Pharma/CRO

JHL Biotech Opens Innovative Biosimilars Manufacturing Facility in China

CHALFONT ST. GILES, UK and WUHAN, CHINA – 10 May 2016 –JHL Biotech (JHL), a biopharmaceutical company, opened the world’s first KUBio™ biopharmaceutical manufacturing facility with single-use bioprocessing technology at a ribbon-cutting ceremony in Wuhan, China today. JHL will use the KUBio manufacturing solution delivered by GE Healthcare to manufacture biosimilars(1) and monoclonal antibodies (mAbs)... Read more

April 15, 2016 Acad, Gov/Utilities Bio/Pharma/CRO Molecular Spectroscopy

Jet fuel, crude oil, diesel blends: Quality control with NIR spectroscopy

Near-Infrared Spectroscopy (NIRS) enables straightforward multiparameter analysis of critical parameters for monitoring the refining of hydrocarbons. NIRS is a nondestructive secondary analysis method, NIRS does not require any handling of chemicals whatsoever, and real-time measurements are performed at the push of a button. NIRS is the ideal method for a wide range of applications: Distillation... Read more